...
首页> 外文期刊>JAMA dermatology >Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins
【24h】

Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins

机译:随后的皮肤黑色素瘤在中度发育性Nevi释放活检,但呈阳性组织学边缘

获取原文
获取原文并翻译 | 示例
           

摘要

Importance? Little evidence exists to guide the management of moderately dysplastic nevi excisionally biopsied without residual clinical pigmentation but with positive histologic margins (hereafter referred to as moderately dysplastic nevi with positive histologic margins).Objective? To determine outcomes and risk for the development of subsequent cutaneous melanoma (CM) from moderately dysplastic nevi with positive histologic margins observed for 3 years or more.Design, Setting, and Participants? A multicenter (9 US academic dermatology sites) retrospective cohort study was conducted of patients 18 years or older with moderately dysplastic nevi with positive histologic margins and 3 years or more of follow-up data collected consecutively from January 1, 1990, to August 31, 2014. Records were reviewed for patient demographics, biopsy type, pathologic findings, and development of subsequent CM at the biopsy site or elsewhere on the body. The χ2 test, the Fisher exact test, and analysis of variance were used to assess univariate association for risk of subsequent CMs, in addition to multivariable logistic regression models. To confirm histologic grading, each site submitted 5 random representative slide cases for central dermatopathologic review. Statistical analysis was performed from October 1, 2017, to June 22, 2018.Main Outcomes and Measures? Development of CM at a biopsy site or elsewhere on the body where there were moderately dysplastic nevi with positive histologic margins.Results? A total of 467 moderately dysplastic nevi with positive histologic margins from 438 patients (193 women and 245 men; mean [SD] age, 46.7 [16.1] years) were evaluated. No cases developed into CM at biopsy sites, with a mean (SD) follow-up time of 6.9 (3.4) years. However, 100 patients (22.8%) developed a CM at a separate site. Results of multivariate analyses revealed that history of CM was significantly associated with the risk of development of subsequent CM at a separate site (odds ratio, 11.74; 95% CI, 5.71-24.15; P??.001), as were prior biopsied dysplastic nevi (odds ratio, 2.55; 95% CI, 1.23-5.28; P?=?.01). The results of a central dermatopathologic review revealed agreement in 35 of 40 cases (87.5%). Three of 40 cases (7.5%) were upgraded in degree of atypia; of these, 1 was interpreted as melanoma in situ. That patient remains without recurrence or evidence of CM after 5 years of follow-up.Conclusions and Relevance? This study suggests that close observation with routine skin surveillance is a reasonable management approach for moderately dysplastic nevi with positive histologic margins. However, having 2 or more biopsied dysplastic nevi (with 1 that is a moderately dysplastic nevus) appears to be associated with increased risk for subsequent CM at a separate site.
机译:重要性?存在很少的证据,以指导中度消化不良Nevi的管理直接生物清单,没有残留的临床色素沉着,但具有阳性组织学边缘(以下用阳性组织学边缘称为适度发育胸腺炎)。目的?确定从中度发育术Nevi的后续皮肤黑素瘤(cm)的结果和风险,3年或更长时间观察到阳性组织学边缘。设计,设置和参与者?多中心(9美国学术皮肤病学遗址)回顾性队列研究是对18岁或以上的患者进行了中度发育性痣的患者进行,具有阳性组织学边缘,3年或更多是从1990年1月1日至8月31日收集的后续数据, 2014年。患者人口统计学,活检类型,病理发现以及在活组织检查部位或身体其他地方的癌症的发育的记录。除了多变量的逻辑回归模型之外,χ2试验,渔民精确测试和方差分析用于评估后续CMS风险的单变量关联。为了确认组织学评分,每个网站提交了5种随机性代表性的幻灯片案件,用于中央皮肤病综述。统计分析于2017年10月1日,到2018年6月22日。在活组织检查部位或身体上的其他地方的癌症的开发,其中具有适度的消化不良痣,具有阳性组织学利润。结果?共有467名中度消除障碍奈维,438名患者(193名妇女和245名男性;意思是[SD]年龄,46.7 [16.1]岁)的阳性组织学利润率。在活组织检查位点没有患者进入CM,平均(SD)随访时间为6.9(3.4)年。然而,100名患者(22.8%)在一个单独的部位开发了一个厘米。多变量分析结果表明,CM的历史与在单独的部位(差距为11.74; 95%CI,5.71-24.15;p≤001)的情况下显着相关的厘米的风险活检消化性奈维(差距比,2.55; 95%CI,1.23-5.28; p?= 01)。中央皮肤病病的结果显示在40例中的35例(87.5%)揭示了协议。 40例(7.5%)中的三种(7.5%)在原型程度上升级;其中,1原位被解释为黑色素瘤。在5年后的后续后,患者仍然没有复发或证据。结论和相关性?该研究表明,与常规皮肤监测的密切观察是具有阳性组织学边缘的中度发育性痣的合理管理方法。然而,具有2个或更多个活检消化性痣(具有1个是中等发育性痣的1个)似乎与随后在单独部位的厘米的风险增加相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号